18 leading hospitals were searching for ways to enhance the chemotherapy patient experience and optimize day hospital capacity. In the current process patients are waiting 45-60% of time, patients and caretakers are severely stressed and day hospital capacity is improperly used.
A new patient pathway
Based on measurements of the patient pathway, survey on patient needs and insights of the caretakers (nurses, doctors and pharmacists), a new pathway was piloted. The key to enable this new pathway is a segmentation of treatments based on patient eligibility (stability of blood sample diagnosis, type of cancer) and stability of prepared cytostaticum.
In 85-90% of the cases, this results in fully plannable pathway where blood is sampled at home, cytostaticum prepared upfront and treatment taking place in day hospital. By decoupling production from treatment, clean room facilities can be centralized and shared over several hospitals or outsourced.
What’s next? Home treatment with compliance monitoring
The next step is home treatment and to follow these patients via telemedicine. A mobile app will allow physicians to remotely monitor the impact and severity of treatment side-effects.In case of oral intake, the same app reminds the patient about when and how to take the necessary medication, improving therapy compliance. In case of intravenous treatments, the guaranteed safety of administration for patient and nurse are primordial. In both cases, the digitalized information flow is in the heart of the new pathway.